logo
Glass Lewis Recommends Stockholders Vote for Change at Brookdale Senior Living Inc.

Glass Lewis Recommends Stockholders Vote for Change at Brookdale Senior Living Inc.

Business Wire19 hours ago
NEW YORK--(BUSINESS WIRE)--Ortelius Advisors, L.P. ('Ortelius') today announced that a third leading independent proxy advisory firm, Glass, Lewis & Co. ('Glass Lewis'), has recommended that stockholders vote FOR the election of Ortelius nominees to the Brookdale Senior Living Inc. (NYSE: BKD) ('Brookdale' or 'Company') Board of Directors, on the WHITE Ortelius proxy card, at the upcoming 2025 Annual Meeting of Stockholders. The recommendation from Glass Lewis builds on supportive commentary already published by Institutional Shareholder Services Inc. ('ISS') and the Egan-Jones Ratings Company ('Egan-Jones') related to Ortelius' campaign for change at Brookdale.
Peter DeSorcy, Managing Member of Ortelius, said:
'We appreciate that Glass Lewis has further confirmed the need for change at Brookdale. With three independent proxy advisors now having validated Ortelius' position, we reiterate our call to stockholders that now is the time to put more qualified and independent voices in the boardroom at Brookdale.
As confirmed by Glass Lewis, ISS, and Egan-Jones, Ortelius' nominees are necessary to effect the critical changes required at Brookdale. If elected, the Ortelius nominees will leverage their well-documented expertise to restore confidence in the critical process to select the Company's next CEO and accelerate the necessary steps to unlock the significant value within Brookdale.
A new and qualified Board is a necessary first step to realizing the potential within Brookdale and we urge our fellow Brookdale stockholders to vote FOR all six of the Ortelius nominees on the WHITE proxy card.'
In its report finding that Ortelius has presented a compelling case for change at Brookdale, Glass Lewis*:
Recognized the validity of Ortelius' campaign to end a history of underperformance at Brookdale:
'The current bout, spearheaded here by Ortelius, largely orbits alternatives relating to Brookdale's portfolio of senior living communities and associated efforts to reverse long-term trendlines which have left the Company trailing comps and fighting to remedy a moribund returns profile.'
Credited Ortelius' public campaign for driving change, with the Board only acting under pressure from Ortelius:
'…notwithstanding the board's contention to the contrary, we believe Brookdale's contest tack – which includes the outwardly sudden and immediately effective termination of longtime CEO Cindy Baier with no heir apparent and the appointment of multiple new board members – very strongly correlates with Ortelius' involvement….and the Dissident's application of significant public pressure. Further, we note certain culpable members continue to serve on the board despite Brookdale's flat-footed refreshment process and decidedly less than laudatory long-term performance.'
'We further note Brookdale's shares experienced a one-day gain of 7.1% following announcement of Ortelius' current campaign (Ventas, Welltower and the S&P 400 gained 1.0%, 0.6% and 3.1%, respectively), suggesting that the Dissident's public involvement was viewed as a prospective catalyst for further value creation.'
'Just as notably, Brookdale's shares surged 8.5% on the announcement that former CEO Cindy Baier would be transitioned with immediate effectiveness (Ventas, Welltower and the S&P 400 gained 2.0%, 2.1% and 1.2%, respectively), clearly reinforcing the notion that her prior executive service was viewed as a valuation millstone for Brookdale. Neither of these developments seem to reflect a ringing endorsement for Brookdale's pre-Ortelius oversight architecture.'
Agreed with Ortelius on the need for Board renewal to bring greater expertise and fresh independent perspectives as well as to hold long-term directors accountable for poor performance:
'…we do believe there exists persuasive cause to advance incremental change to bolster key competencies, hold certain long-term directors accountable and provide fresh insight into a critical and, to date, murky succession initiative.'
'...we similarly don't believe investors should forego the opportunity to promote incremental change and firm accountability as the Company moves through the early innings of a pivotal strategic and financial transition.'
Validated Ortelius' criticisms about Brookdale's operating performance:
'…for all the board's public posturing, basic facts should prevail here: slightly more than a third of the Company's properties presently sit at lower than 75% occupancy, with a substantial subset of that group sitting at less than 70%.'
Echoed Ortelius' well-founded concerns about Brookdale's occupancy rates:
'Ortelius does, however, reasonably note that Brookdale's occupancy fell further than Ventas and Welltower amid COVID headwinds and that Brookdale currently remains below senior housing occupancy rates posted by those comps, suggesting the Company's emergent rebound still leaves Brookdale off peer levels.'
Confirmed Ortelius' commentary on Brookdale's poor financial performance including lagging net operating income (NOI) margins and excessive leverage:
'We do believe Ortelius offers persuasive commentary regarding depressed NOI margins.'
'…NOI margins do indeed appear to remain below both pre-COVID figures and margins posted by Ventas and Welltower, again suggesting that Brookdale's recovery from long-term performance trends remains very much a work in progress.'
'… there appears to be little meaningful debate that Brookdale presently remains heavily levered.'
Confirmed that Ortelius' plan to sell underperforming properties is well conceived and viable:
'…we note central elements of Ortelius' plan critically rely on exiting Brookdale's existing portfolio of leased properties while concurrently monetizing the Company's underperforming owned assets, leaving Brookdale with an optimized pool of high-quality communities which would be expected to unlock significant value for investors.'
Questioned Brookdale's governance practices and the Board's capacity to lead a credible CEO search process given concerns around the Board's recent director appointments:
'Two of the four directors recently appointed to the Brookdale board (Mr. Fioravanti and Ms. Mace) were identified by Ms. Baier, while one other (Mr. Hausman) was identified by current chair and interim CEO Denise Warren. That these appointments do not appear to reflect legacy relationships is arguably much less important than the impression that the nominating and corporate governance committee – currently helmed by Victoria Freed – expressly skirted retaining an independent search firm in favor of recommendations submitted by Brookdale's senior executives, one of which, Ms. Baier, appears to have been well out of favor with investors. This framework does not go particularly far in establishing that a broad, independent, externally validated candidate identification process was prioritized, and does little to deflect the implication that key members of leadership have increasingly self-selected the members of the board to which they report.'
'Brookdale indicates it retained Spencer Stuart to aid in CEO succession matters as early as November 2024. However, currently available materials do not give a particularly firm impression that any significant progress was made on those matters during the roughly five-month period between retention and Ms. Baier's departure. For the sake of clarity, our engagement with the board indicated five of seven investors with which Brookdale engaged after Ortelius' emergence expressed a desire for immediate management change. That the board thereafter swiftly accelerated Ms. Baier's exit in lieu of purportedly ongoing succession processes suggests to us that its members realized relatively late that they were materially out of phase with investor sentiment and thus sought to blunt possible solicitation vulnerabilities narratives by securing Ms. Baier's immediate resignation despite the apparent absence of any qualified long-term replacement.'
'Ms. Warren is slated to serve as interim CEO until a permanent successor to Ms. Baier is named. Notably, Brookdale's own skills matrix indicates senior housing is not among Ms. Warren's core competencies (an assessment which curiously clashes with recent materials published by Brookdale stating Ms. Warren has 'directly relevant senior living experience').'
'...the fact that Ms. Warren was selected as pro tem CEO over any existing employee seems to invite immediate scrutiny regarding the depth of Brookdale's bench and the efficacy of the board's succession architecture.'
'...closer scrutiny suggests key elements of the Company's refresh – including what seems to be nominal involvement from the nominating and corporate governance committee and the continuation of an objectively atypical and functionally reactive CEO succession process – suggest fresh perspectives could be beneficial here.'
Endorsed Ortelius nominees Steven J. Insoft and Steven Vick for bringing important skills and perspectives to the Board:
'We believe both Ortelius candidates offer valuable senior housing and real estate expertise at a critical juncture, with particular attention to Brookdale's ongoing portfolio optimization efforts. Their elections in place of Ms. Freed and Mr. Wielansky would further demonstrate board refreshment directly predicated on exercise of the shareholder franchise, rather than on deference to members of management.'
Recommended 'Withhold' votes on long tenured Brookdale directors Lee Wielansky, Chair of the Investment Committee, and Victoria Freed, Chair of the Nominating and Governance Committee:
'Withholding votes from incumbent nominees Freed and Wielansky – Ms. Freed and Mr. Wielansky are, ex Ms. Warren, the longest serving members of the Brookdale board and thus the most readily accountable for the Company's comparatively poor long-term performance'
'Mr. Wielansky's purportedly valuable strategic insight and real estate expertise should, in the context of Brookdale's long-term arc, warrant particular scrutiny by investors, while Ms. Freed's experience seems to have very little crossover with the Company's core operations or ongoing strategic and financial initiatives.'
'Importantly, both directors have overseen significantly subpar shareholder returns during their respective tenures. We are further concerned that Ms. Freed, as chair of the nominating and corporate governance committee, has heavily deferred to the recommendations of current and former senior executives during Brookdale's recent board refresh, a tack which, taken together with the Company's muddled succession effort, reflects unfavorably on the fundamental efficacy of Brookdale's existing oversight architecture.'
Your vote is important, no matter how many or how few shares of common stock you own. Ortelius urges you to sign, date, and return the WHITE universal proxy card today to vote 'FOR' the election of all six Ortelius nominees and in accordance with Ortelius' recommendations on the other proposals on the agenda for the Annual Meeting.
Stockholders who have questions or require assistance in voting their WHITE Proxy Card, or those who require copies of Ortelius' proxy materials, should contact: Saratoga Proxy Consulting LLC at (888) 368-0379 or info@saratogaproxy.com
*Permission to use quotations from the report was neither sought nor obtained.
Additional Information
Ortelius Advisors, L.P., together with the other participants in its proxy solicitation (collectively, 'Ortelius'), has filed a definitive proxy statement and accompanying WHITE universal proxy card with the Securities and Exchange Commission ('SEC') to be used to solicit votes for the election of Ortelius' slate of highly-qualified director nominees at the 2025 annual meeting of stockholders (the 'Annual Meeting') of Brookdale Senior Living Inc., a Delaware corporation (the 'Company'). Stockholders are advised to read the proxy statement and any other documents related to the solicitation of stockholders of the Company in connection with the Annual Meeting because they contain important information, including information relating to the participants in Ortelius' proxy solicitation. These materials and other materials filed by Ortelius with the SEC in connection with the solicitation of proxies are available at no charge on the SEC's website at http://www.sec.gov. The definitive proxy statement and other relevant documents filed by Ortelius with the SEC are also available, without charge, by directing a request to Ortelius' proxy solicitor, Saratoga Proxy Consulting LLC, at its toll-free number (888) 368-0379 or via email at info@saratogaproxy.com.
Ortelius is a research-intensive, fundamental-based, activist-oriented alternative investment management firm focused on event-driven opportunities.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Bloomberg Surveillance: All-Time Highs
Bloomberg Surveillance: All-Time Highs

Bloomberg

time4 minutes ago

  • Bloomberg

Bloomberg Surveillance: All-Time Highs

Watch Tom and Paul LIVE every day on YouTube: Bloomberg Surveillance hosted by Tom Keene & Paul Sweeney July 1st, 2025 Featuring: 1) Bob Michele, CIO: Fixed Income at JPMorgan Asset Management, joins for an extended discussion on the outlook for yields and why there could be more bond investment in 2025. The 10-year Treasury yield declined four basis points to 4.19% in the early morning as investors increased wagers on the scale of potential Federal Reserve interest rate cuts this year. 2) Cam Dawson, CIO at NewEdge Wealth, talks about equity all-time highs and raising the pain trade. US equity futures retreated slightly after the S&P 500 notched its best quarter since 2023, as investors monitor progress on trade talks and wrangling in Washington over President Trump's tax bill. 3) George Goncalves, Head: US Macro Strategy MUFG Securities, Americas, talks about the outlook for US economic growth should the tax bill pass and his economic projections for 2025 as the labor market shows signs of weakening. Investors are also watching for a slew of economic data, including PMI readings and the US job openings report, ahead of Thursday's nonfarm payrolls, and a discussion on monetary policy at the European Central Bank's annual retreat. 4) Michael Lasser, Equity Research Analyst: Consumer Hardline Staples at UBS, explores the potential ramifications of the bill on an aggregate consumer spending level, as well as the potential impacts for each consumer subsector and individual stocks. US consumer spending declined 0.3% in May, the most since the start of the year, indicating uncertainty around the Trump administration's economic policies is weighing on growth. 5) Lisa Mateo joins with the latest headlines in newspapers across the US, including a story from The Athletic on ESPN and MLB resuming broadcasting rights talks and a WSJ story on why the July 4th BBG may get more expensive.

Elevance Health Insiders Sold US$6.9m Of Shares Suggesting Hesitancy
Elevance Health Insiders Sold US$6.9m Of Shares Suggesting Hesitancy

Yahoo

time5 minutes ago

  • Yahoo

Elevance Health Insiders Sold US$6.9m Of Shares Suggesting Hesitancy

Over the past year, many Elevance Health, Inc. (NYSE:ELV) insiders sold a significant stake in the company which may have piqued investors' interest. When evaluating insider transactions, knowing whether insiders are buying is usually more beneficial than knowing whether they are selling, as the latter can be open to many interpretations. However, if numerous insiders are selling, shareholders should investigate more. While insider transactions are not the most important thing when it comes to long-term investing, we would consider it foolish to ignore insider transactions altogether. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. In the last twelve months, the biggest single sale by an insider was when the Executive VP & President of Commercial Health Benefits, Charles Kendrick, sold US$3.2m worth of shares at a price of US$432 per share. That means that an insider was selling shares at around the current price of US$396. While insider selling is a negative, to us, it is more negative if the shares are sold at a lower price. Given that the sale took place at around current prices, it makes us a little cautious but is hardly a major concern. Elevance Health insiders didn't buy any shares over the last year. The chart below shows insider transactions (by companies and individuals) over the last year. If you want to know exactly who sold, for how much, and when, simply click on the graph below! View our latest analysis for Elevance Health If you like to buy stocks that insiders are buying, rather than selling, then you might just love this free list of companies. (Hint: Most of them are flying under the radar). Over the last three months, we've seen significant insider selling at Elevance Health. Specifically, Executive VP & CFO Mark Kaye ditched US$1.9m worth of shares in that time, and we didn't record any purchases whatsoever. In light of this it's hard to argue that all the insiders think that the shares are a bargain. For a common shareholder, it is worth checking how many shares are held by company insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. Elevance Health insiders own 0.1% of the company, currently worth about US$103m based on the recent share price. This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders. An insider hasn't bought Elevance Health stock in the last three months, but there was some selling. And there weren't any purchases to give us comfort, over the last year. The company boasts high insider ownership, but we're a little hesitant, given the history of share sales. So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing. To assist with this, we've discovered 1 warning sign that you should run your eye over to get a better picture of Elevance Health. But note: Elevance Health may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt. For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Stock market today: Nasdaq pops, leading Dow and S&P 500 higher amid Vietnam trade deal, weak jobs data
Stock market today: Nasdaq pops, leading Dow and S&P 500 higher amid Vietnam trade deal, weak jobs data

Yahoo

time14 minutes ago

  • Yahoo

Stock market today: Nasdaq pops, leading Dow and S&P 500 higher amid Vietnam trade deal, weak jobs data

US stocks moved higher on Wednesday as optimism over US trade deals rose at the same time that more signs of an intensifying labor market slowdown bolstered the case for the Federal Reserve to start cutting interest rates. The Dow Jones Industrial Average (^DJI) rose around 0.1%. Meanwhile, the S&P 500 (^GSPC) rose around 0.3%, keeping potential new record high in sight. The Nasdaq Composite (^IXIC) moved up about 0.7%, with Apple (AAPL) stock rising after an upgrade from Jefferies (JEF) analysts and Tesla (TSLA) shares climbing after the EV maker produced more vehicles globally than expected in the second quarter even as sales plummeted. The benchmark S&P 500 and Nasdaq moved to session highs after President Trump announced a trade deal with Vietnam, lifting investor hopes that more agreements will come before the July 9 tariff pause deadline. Meanwhile, the labor market showed more signs of a cooldown in June. ADP data showed US private employers unexpectedly cut 33,000 jobs in the month, badly missing expectations of around 98,000 jobs added. It was the first month of job losses in the private sector in over two years. The data lays the ground for the release of the June US jobs report on Thursday, seen as a key factor for the Fed as investors bet an interest-rate cut could land sooner rather than later. According to CME data, the majority of Fed watchers still do not expect the central bank to cut rates in July. But almost all are betting on at least one rate cut by September, with over 20% now pricing in two cuts by that meeting. Read more: The latest on Trump's tariffs Trump's "One Big Beautiful Bill" is also in focus as it heads to the House after clearing the Senate thanks to Vice President JD Vance's tie-breaking vote. Insurance stocks fell across the board Wednesday, as the bill would slash federal health spending on Medicaid. But split Republican factions threaten to delay a potential final vote as Trump pushes to sign it by July 4. Footwear stocks led by Nike rose in morning trade on Wednesday after President Trump took to his social media platform Truth Social to share that he "made a Trade Deal with Vietnam." Nike (NKE), On Holding (ONON), Deckers (DECK), and Lululemon (LULU) spiked in immediate response to the news. Retail and footwear stocks tempered initial gains as Trump outlined details of the deal in a subsequent post, which said Vietnam will pay a 20% tariff on all good sent into the US and a 40% tariff on goods that are subject to transshipping, meaning routed through Vietnam with a different country of origin, like China. After an initial pop to rise as much as 4%, Nike stock was up about 1.7% in mid-morning trade on Wednesday. Shares of ON were up more than 3.5% to lead the rally among footwear names, while Deckers and Lululemon shares were fractionally higher. Read more here. Intel stock fell 3.7% after Reuters reported that the struggling chipmaker's new CEO is considering scrapping the company's long-awaited 18A technology for external customers — a chip manufacturing process that analysts have said is Intel's greatest hope for succeeding in a turnaround and becoming competitive with TSMC (TSM). According to Reuters, CEO Lip-Bu Tan has said that 18A was losing its appeal with customers. So far, Amazon (AMZN) and Microsoft (MSFT) have signed on to build their own chips using Intel's 18A process. Intel opened up its manufacturing business to outside clients in 2021 under former CEO Pat Gelsinger. But Wall Street analysts, investors, and executives grew exasperated with his strategy and what they saw as unrealistic goals for the business, which lost $13.4 billion in 2024 despite recording a revenue of $17.5 billion. Tan joined the company in March, and analysts and former executives told Yahoo Finance the new CEO needed to release 18A for outside customers to show that the company can execute after a history of delays and cancellations of its products and manufacturing processes. But Tan would instead like to focus on 14A, the manufacturing technology that is the successor to 18A. President Trump announced a trade deal with Vietnam, lifting investor sentiment that more agreements could come before the July 9 tariff-pause deadline. "The Terms are that Vietnam will pay the United States a 20% Tariff on any and all goods sent into our Territory, and a 40% Tariff on any Transshipping," Trump wrote on social media on Wednesday morning. "In return, Vietnam will do something that they have never done before, give the United States of America TOTAL ACCESS to their Markets for Trade," he added. "It is my opinion that the SUV or, as it is sometimes referred to, Large Engine Vehicle, which does so well in the United States, will be a wonderful addition to the various product lines within Vietnam," wrote Trump. Investors have been closely watching developments on the trade front as July 9 approaches — the deadline following a 90-day pause of reciprocal tariffs announced in April. The US recently announced a framework agreement with China, a major trading partner. Insurance stocks dropped across the board Wednesday following the passage during the prior trading session of Trump's "big, beautiful" tax and spending bill, which would gut federal healthcare spending over the next decade. UnitedHealth (UNH) fell nearly 3%, while Aetna parent company CVS Health (CVS) dropped over 2%. Cigna (CI) declined 3%, while Elevance Health (ELV) fell almost 9%. The megabill's provision to slash federal spending on Medicaid and Affordable Care Act marketplaces by about $1 trillion would leave almost 12 million people without insurance by 2034, NPR reported. Tesla stock climbed nearly 3% early Wednesday after the EV maker reported global electric vehicle deliveries that came in below Wall Street's low projections but produced more cars than expected. Tesla said Wednesday it delivered 384,122 EVs in the second quarter, less than the 389,407 projected by Wall Street analysts tracked by Bloomberg consensus estimates. The company's deliveries for the period marked a 13% drop from the prior year, but an increase from the 336,681 vehicles delivered in the first quarter. Read the full story here. Apple (AAPL) stock climbed about 1% Wednesday before the market open following an upgrade from analysts at Jefferies, who raised their rating to Hold from Underperform previously. Citing Counterpoint Research, Jefferies analyst Edison Lee said global iPhone sales rose 15% in April and May from the prior year, the strongest growth since the third quarter of 2021. Lee estimated that iPhone sales in China grew 19% in that period, partly due to targeted discounts and government subsidies as well as "pulled-in demand," or Chinese consumers buying phones ahead of anticipated tariffs. "This is a strong sign that AAPL is determined to defend market share in China, and Chinese consumers are still willing to buy iPhone at lower prices," Lee wrote. But he also said the release of the iPhone 17 in the second half of 2025 may not provide the boost Apple needs. Lee wrote that "sales could be at risk since there remains a lack of new features, and AI is not yet a game changer." Apple shares jumped 1.3% Tuesday following a report from Bloomberg that the iPhone maker is considering using AI technology from startups Anthropic ( or OpenAI ( to power a new version of Siri. Still, the stock was down 17% for the 12 months through Tuesday. Nvidia (NVDA) stock continued to retreat from its record high of $157.99 on Monday. Shares were down 1.2% in premarket trading. The AI chipmaker had reclaimed the top spot among the most valued companies worldwide in June, with a market cap of around $3.73 trillion, as of July 1. Microsoft (MSFT), the second most valued company, has a market cap of roughly $3.65 trillion. From Reuters: Read more here. Private employers unexpectedly cut 33,000 jobs in June, the latest signal of an intensifying slowdown in the US labor market. On Wednesday, data from ADP showed private payrolls fell by 33,000 last month in June, below the 29,000 job gains seen in May and the 98,000 additions expected by economists. This marked the first month of job losses in the private sector since March 2023. May's initial reading of 37,000 private payroll additions had been the lowest monthly total since March '23. "Though layoffs continue to be rare, a hesitancy to hire and a reluctance to replace departing workers led to job losses last month," ADP chief economist Nela Richardson said in the release. "Still, the slowdown in hiring has yet to disrupt pay growth." Read more here. Some of the world's most influential stocks are dragging the S&P 500 Index (^GSPC) down. The names Apple (AAPL), Tesla (TSLA) and Alphabet (GOOG, GOOGL) — part of the Mag 7 and synonymous with growth and value seem to be preventing the S&P 500 from reaching further highs. Bloomberg News reports: Read more here. Apple's (AAPL) is reportedly considering using AI tech from outside firms to power new version of Siri. Meta CEO Mark Zuckerberg is on an aggressive recruitment drive to poach top AI researchers and engineers. They're both signs of a key shift, Yahoo Finance's Hamza Shaban reports in today's Morning Brief: Read more here. Tesla (TSLA) is expected to report yet another quarter of declining global deliveries on Wednesday, though disappointing sales are nothing new for investors and analysts following the company. Data for June has brought a mixed message. Sales dropped for a sixth straight month in France, Sweden, Denmark and Italy, but rose in Norway and Spain — an early sign that the revamped Model Y is getting some buyers. Shares of Tesla were edging into the green in premarket before the quarterly data, following a 5% loss on Tuesday as CEO Elon Musk's feud with President Trump flared up again. Yahoo Finance's Pras Subramanian reports: Read more here. Earnings: No notable earnings releases.. Economic data: MBA Mortgage Applications (week ending June 27); ADP employment change (June); S&P Global US services PMI (May final); Challenger job cuts (May) Here are some of the biggest stories you may have missed overnight and early this morning: Apple and Meta are proving it: AI is going corporate Bets on 'Goldilocks' stocks bump up against reality Trump's 35% threat feeds Japan's worst-case tariff fears 'Irrational exuberance' stock gauge sparks fresh bubble worries Opinion: Musk is right about the Trump tax bill's failures Tesla's quarterly deliveries to fall short again Paramount settles Trump's '60 Minutes' suit for $16 million Bessent: Fed could lower interest rates by September Social Security checks slashed for millions this month Shares of Centene (CNC) tumbled over 25% in premarket trading after the healthcare insurer withdrew its financial guidance for 2025, warning that its earnings will fall far short of expectations. The company said late Tuesday that recent data showed that fewer people were enrolling in the Medicaid and Affordable Care Act marketplaces, and those who did enrol were sicker than expected. Those trends went against Centene's assumptions are likely to lead to a shortfall of $1.8 billion in federal payouts, the company said. Centene expects the issue to pull its full-year earnings per shares down by $2.75 a share. Wall Street had previously estimated adjusted EPS of $7.28. Shares of industry peers Elevance Health (ELV) and Oscar Health (OSCR) also struggled, down 4% and 7%, respectively. Here are some top stocks trending on Yahoo Finance in premarket trading: Centene Corporation (CNC) slumped 26% in premarket trading on Wednesday after withdrawing its financial guidance for 2025, warning that earnings will fall short of expectations. Centene is following in the footsteps of fellow insurance group, UnitedHealth (UNH), which pulled its guidance for the year and also replaced its chief executive. This latest news from Centene may add to investor nervousness when it comes to the insurance sector. Wolfspeed (WOLF) stock fell 8% before the bell today after the semiconductor company filed for a Chapter 11 bankruptcy. Intel (INTC) stock fell 1% in premarket trading following the new chief executive's plan to exploring a big change to its contract manufacturing business. If implemented, the new strategy for what Intel calls its "foundry" business would entail no longer marketing certain chipmaking technology, which the company had long developed, to external customers, the people said. If investors are expecting a seasonal lift for Asian equities this summer, they may have to think again. Tariff pressures and macroeconomic concerns have started to dampen sentiment. Bloomberg News reports: Read more here. Markets across the Asia-Pacific region saw mixed trading early morning on Wednesday, with investors eyeing the potential of US interest rate cuts and the fast-approaching July 9 tariff deadline for deals to be struck between the US and major trading partners worldwide. Singapore's benchmark, the Straits Times Index (^STI), gained 0.5% to hit a record high of 4009.15 points as of 00:20 (UTC-4). The move saw the index crossing past the 4000 threshold for the second time on record. Australia and Hong Kong led gains as Australia's S&P/ASX 200 (^AXJO) rose 0.4% and the Hang Seng Index (^HSI) popped 0.7%. Japan saw loss in the country's major gauge as the benchmark Nikkei 225 (^N225) slipped 0.7%. Korea's Kospi (^KS11) cratered 1.2% as Trump ratcheted up pressure on the country to finalize a trade deal. Mainland China's CSI 300 ( hovered near the baseline. Reuters reports: Footwear stocks led by Nike rose in morning trade on Wednesday after President Trump took to his social media platform Truth Social to share that he "made a Trade Deal with Vietnam." Nike (NKE), On Holding (ONON), Deckers (DECK), and Lululemon (LULU) spiked in immediate response to the news. Retail and footwear stocks tempered initial gains as Trump outlined details of the deal in a subsequent post, which said Vietnam will pay a 20% tariff on all good sent into the US and a 40% tariff on goods that are subject to transshipping, meaning routed through Vietnam with a different country of origin, like China. After an initial pop to rise as much as 4%, Nike stock was up about 1.7% in mid-morning trade on Wednesday. Shares of ON were up more than 3.5% to lead the rally among footwear names, while Deckers and Lululemon shares were fractionally higher. Read more here. Intel stock fell 3.7% after Reuters reported that the struggling chipmaker's new CEO is considering scrapping the company's long-awaited 18A technology for external customers — a chip manufacturing process that analysts have said is Intel's greatest hope for succeeding in a turnaround and becoming competitive with TSMC (TSM). According to Reuters, CEO Lip-Bu Tan has said that 18A was losing its appeal with customers. So far, Amazon (AMZN) and Microsoft (MSFT) have signed on to build their own chips using Intel's 18A process. Intel opened up its manufacturing business to outside clients in 2021 under former CEO Pat Gelsinger. But Wall Street analysts, investors, and executives grew exasperated with his strategy and what they saw as unrealistic goals for the business, which lost $13.4 billion in 2024 despite recording a revenue of $17.5 billion. Tan joined the company in March, and analysts and former executives told Yahoo Finance the new CEO needed to release 18A for outside customers to show that the company can execute after a history of delays and cancellations of its products and manufacturing processes. But Tan would instead like to focus on 14A, the manufacturing technology that is the successor to 18A. President Trump announced a trade deal with Vietnam, lifting investor sentiment that more agreements could come before the July 9 tariff-pause deadline. "The Terms are that Vietnam will pay the United States a 20% Tariff on any and all goods sent into our Territory, and a 40% Tariff on any Transshipping," Trump wrote on social media on Wednesday morning. "In return, Vietnam will do something that they have never done before, give the United States of America TOTAL ACCESS to their Markets for Trade," he added. "It is my opinion that the SUV or, as it is sometimes referred to, Large Engine Vehicle, which does so well in the United States, will be a wonderful addition to the various product lines within Vietnam," wrote Trump. Investors have been closely watching developments on the trade front as July 9 approaches — the deadline following a 90-day pause of reciprocal tariffs announced in April. The US recently announced a framework agreement with China, a major trading partner. Insurance stocks dropped across the board Wednesday following the passage during the prior trading session of Trump's "big, beautiful" tax and spending bill, which would gut federal healthcare spending over the next decade. UnitedHealth (UNH) fell nearly 3%, while Aetna parent company CVS Health (CVS) dropped over 2%. Cigna (CI) declined 3%, while Elevance Health (ELV) fell almost 9%. The megabill's provision to slash federal spending on Medicaid and Affordable Care Act marketplaces by about $1 trillion would leave almost 12 million people without insurance by 2034, NPR reported. Tesla stock climbed nearly 3% early Wednesday after the EV maker reported global electric vehicle deliveries that came in below Wall Street's low projections but produced more cars than expected. Tesla said Wednesday it delivered 384,122 EVs in the second quarter, less than the 389,407 projected by Wall Street analysts tracked by Bloomberg consensus estimates. The company's deliveries for the period marked a 13% drop from the prior year, but an increase from the 336,681 vehicles delivered in the first quarter. Read the full story here. Apple (AAPL) stock climbed about 1% Wednesday before the market open following an upgrade from analysts at Jefferies, who raised their rating to Hold from Underperform previously. Citing Counterpoint Research, Jefferies analyst Edison Lee said global iPhone sales rose 15% in April and May from the prior year, the strongest growth since the third quarter of 2021. Lee estimated that iPhone sales in China grew 19% in that period, partly due to targeted discounts and government subsidies as well as "pulled-in demand," or Chinese consumers buying phones ahead of anticipated tariffs. "This is a strong sign that AAPL is determined to defend market share in China, and Chinese consumers are still willing to buy iPhone at lower prices," Lee wrote. But he also said the release of the iPhone 17 in the second half of 2025 may not provide the boost Apple needs. Lee wrote that "sales could be at risk since there remains a lack of new features, and AI is not yet a game changer." Apple shares jumped 1.3% Tuesday following a report from Bloomberg that the iPhone maker is considering using AI technology from startups Anthropic ( or OpenAI ( to power a new version of Siri. Still, the stock was down 17% for the 12 months through Tuesday. Nvidia (NVDA) stock continued to retreat from its record high of $157.99 on Monday. Shares were down 1.2% in premarket trading. The AI chipmaker had reclaimed the top spot among the most valued companies worldwide in June, with a market cap of around $3.73 trillion, as of July 1. Microsoft (MSFT), the second most valued company, has a market cap of roughly $3.65 trillion. From Reuters: Read more here. Private employers unexpectedly cut 33,000 jobs in June, the latest signal of an intensifying slowdown in the US labor market. On Wednesday, data from ADP showed private payrolls fell by 33,000 last month in June, below the 29,000 job gains seen in May and the 98,000 additions expected by economists. This marked the first month of job losses in the private sector since March 2023. May's initial reading of 37,000 private payroll additions had been the lowest monthly total since March '23. "Though layoffs continue to be rare, a hesitancy to hire and a reluctance to replace departing workers led to job losses last month," ADP chief economist Nela Richardson said in the release. "Still, the slowdown in hiring has yet to disrupt pay growth." Read more here. Some of the world's most influential stocks are dragging the S&P 500 Index (^GSPC) down. The names Apple (AAPL), Tesla (TSLA) and Alphabet (GOOG, GOOGL) — part of the Mag 7 and synonymous with growth and value seem to be preventing the S&P 500 from reaching further highs. Bloomberg News reports: Read more here. Apple's (AAPL) is reportedly considering using AI tech from outside firms to power new version of Siri. Meta CEO Mark Zuckerberg is on an aggressive recruitment drive to poach top AI researchers and engineers. They're both signs of a key shift, Yahoo Finance's Hamza Shaban reports in today's Morning Brief: Read more here. Tesla (TSLA) is expected to report yet another quarter of declining global deliveries on Wednesday, though disappointing sales are nothing new for investors and analysts following the company. Data for June has brought a mixed message. Sales dropped for a sixth straight month in France, Sweden, Denmark and Italy, but rose in Norway and Spain — an early sign that the revamped Model Y is getting some buyers. Shares of Tesla were edging into the green in premarket before the quarterly data, following a 5% loss on Tuesday as CEO Elon Musk's feud with President Trump flared up again. Yahoo Finance's Pras Subramanian reports: Read more here. Earnings: No notable earnings releases.. Economic data: MBA Mortgage Applications (week ending June 27); ADP employment change (June); S&P Global US services PMI (May final); Challenger job cuts (May) Here are some of the biggest stories you may have missed overnight and early this morning: Apple and Meta are proving it: AI is going corporate Bets on 'Goldilocks' stocks bump up against reality Trump's 35% threat feeds Japan's worst-case tariff fears 'Irrational exuberance' stock gauge sparks fresh bubble worries Opinion: Musk is right about the Trump tax bill's failures Tesla's quarterly deliveries to fall short again Paramount settles Trump's '60 Minutes' suit for $16 million Bessent: Fed could lower interest rates by September Social Security checks slashed for millions this month Shares of Centene (CNC) tumbled over 25% in premarket trading after the healthcare insurer withdrew its financial guidance for 2025, warning that its earnings will fall far short of expectations. The company said late Tuesday that recent data showed that fewer people were enrolling in the Medicaid and Affordable Care Act marketplaces, and those who did enrol were sicker than expected. Those trends went against Centene's assumptions are likely to lead to a shortfall of $1.8 billion in federal payouts, the company said. Centene expects the issue to pull its full-year earnings per shares down by $2.75 a share. Wall Street had previously estimated adjusted EPS of $7.28. Shares of industry peers Elevance Health (ELV) and Oscar Health (OSCR) also struggled, down 4% and 7%, respectively. Here are some top stocks trending on Yahoo Finance in premarket trading: Centene Corporation (CNC) slumped 26% in premarket trading on Wednesday after withdrawing its financial guidance for 2025, warning that earnings will fall short of expectations. Centene is following in the footsteps of fellow insurance group, UnitedHealth (UNH), which pulled its guidance for the year and also replaced its chief executive. This latest news from Centene may add to investor nervousness when it comes to the insurance sector. Wolfspeed (WOLF) stock fell 8% before the bell today after the semiconductor company filed for a Chapter 11 bankruptcy. Intel (INTC) stock fell 1% in premarket trading following the new chief executive's plan to exploring a big change to its contract manufacturing business. If implemented, the new strategy for what Intel calls its "foundry" business would entail no longer marketing certain chipmaking technology, which the company had long developed, to external customers, the people said. If investors are expecting a seasonal lift for Asian equities this summer, they may have to think again. Tariff pressures and macroeconomic concerns have started to dampen sentiment. Bloomberg News reports: Read more here. Markets across the Asia-Pacific region saw mixed trading early morning on Wednesday, with investors eyeing the potential of US interest rate cuts and the fast-approaching July 9 tariff deadline for deals to be struck between the US and major trading partners worldwide. Singapore's benchmark, the Straits Times Index (^STI), gained 0.5% to hit a record high of 4009.15 points as of 00:20 (UTC-4). The move saw the index crossing past the 4000 threshold for the second time on record. Australia and Hong Kong led gains as Australia's S&P/ASX 200 (^AXJO) rose 0.4% and the Hang Seng Index (^HSI) popped 0.7%. Japan saw loss in the country's major gauge as the benchmark Nikkei 225 (^N225) slipped 0.7%. Korea's Kospi (^KS11) cratered 1.2% as Trump ratcheted up pressure on the country to finalize a trade deal. Mainland China's CSI 300 ( hovered near the baseline. Reuters reports: Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store